French Clarify Use Of Plaquenil & Kaletra In COVID-19
Products Can Be Used In Hospitals And Clinical Trials
France is exploring the use of hydroxychloroquine and lopinavir/ritonavir in COVID-19, but only in hospitalized patients and in clinical trials, and has banned all exports of the products to avoid possible shortages.
